Mylan CEO to testify before House over EpiPen pricing: lawmakers

WASHINGTON (Reuters) - Mylan NL Chief Executive Officer Heather Bresch will appear at a Sept. 21 congressional hearing over price increases for its allergy auto-injector EpiPen, the U.S. House of Representatives Oversight Committee said in a statement on Wednesday.

Mylan CEO to testify before House over EpiPen pricing: lawmakers
Read More


Bagikan Berita Ini